Back to results
US 9,751,831 B2Granted
Blood brain barrier-penetrating oximes for cholistenerases reactivation
AssigneeHuman BioMolecular Research Institute
InventorsJohn R. Cashman, Jarosiaw Kalisiak
Life of this patent
Estimating the term…
Abstract
The invention describes pharmaceutical agents capable of crossing the blood brain barrier to protect against organophosphate pesticides and nerve agents or other electrophiles by reactivating inhibited cholinesterase (i.e., acetylcholinesterase and butyrylcholinesterase) and other proteins in the peripheral and central nervous system.
Claims6
A compound of Formula V, VI or VII:
- or a pharmaceutically acceptable salt thereof, wherein
- R is selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, alkylidenyl, alkenylidenyl, alkoxy, halo, haloalkyl, azidoalkyl, hydroxy, hydroxyalkyl, aryl, heteroaryl, heterocycle, cycloalkyl, alkoxycarbonyl, alkylimino, alkylamino, acylamino, trifluoromethylalkyl, trifluoromethoxyalkyl, carboxyalkyl, ketoalkyl, thioalkyl, alkylsulfinyl, alkylsulfonyl, amidinoalkyl, guanidynoalkyl, oximoalkyl, NRxRy and COORy wherein each Rx and Ry are independently hydrogen, alkyl, alkenyl, aryl, heteroaryl, heterocycle, cycloalkyl or hydroxy.
Dependencies are inferred from the claim text.